Menu

With a unique combination of machine learning & imaging technology, PatenSee standardizes best clinical practices

algorithms to identify
emerging patterns over time (“fingerprints”), indicating developing stenosis

With a unique combination of machine learning & imaging technology, PatenSee standardizes best clinical practices

Algorithms to identify
emerging patterns over time (“fingerprints”), indicating developing stenosis

PatenSee’s System

                                                                             Multi-modal imaging technologies, AI and machine learning

Look

Subdermal imaging of collateral veins

3D imaging – observes the status of the vascular access

Listen & Feel

Listens optically (no-contact) – detects the change in pulsatility and vibration, along with stethoscope-like features

Machine Learning

Provides a model simulating the full status of the patient’s vascular access, with potential early identification of clinically-relevant stenosis

PatenSee’s Solution

Expedites and Automizes

Delivers standardized assessment in 1-2 minutes.

Increased Sensitivity and Specificity

The patient’s vascular access is checked by the same PatenSee 3D imaging solution every time, rather than subjective and variable physical examinations.

Democratizes Treatment

The AI driven technology enables standardized clinical practices to be universally available.

Seamless Fit in Dialysis Patient Workflow

Back To Top
© Patensee 2025
Powered by: SPInc

PatenSee is a clinical-stage medical device company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients. Using advanced, multi-modal imaging technologies, AI and machine learning, PatenSee’s device alerts caregivers of vascular access stenosis risk at the earliest stage, enabling timely interventions to protect the patient’s hemodialysis lifeline, improve the quality of care and prolong the life of the fistula. 


PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.